Theralase (TSXV:TLT) and Ferring Pharmaceuticals will evaluate a new combination therapy for high-risk non-muscle invasive bladder cancer.

Theralase (TSXV:TLT) and Ferring Pharmaceuticals will evaluate a new combination therapy for high-risk non-muscle invasive bladder cancer.

Stem cells use inbuilt map for genetic navigation to repair stroke damage. Explore how brain connections and motor skills are restored.

A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis patients.

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise. During tumour excision,...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise. During tumour excision,...

Indian scientists at the Raman Research Institute have developed a non-invasive technique to measure the local density of atoms in quantum systems...

For the first time,...

For the first time,...

A new technology has been developed that enables cuffless non-invasive blood pressure monitoring by using ultrasonic to track real-time changes in...